Published in J Trauma on May 01, 1981
Determinants of mortality for necrotizing soft-tissue infections. Ann Surg (1995) 3.65
Necrotizing soft tissue infections. Risk factors for mortality and strategies for management. Ann Surg (1996) 3.52
Improved results from a standardized approach in treating patients with necrotizing fasciitis. Ann Surg (1987) 1.71
Necrotizing fasciitis: strategies for diagnosis and management. World J Emerg Surg (2007) 1.63
Necrotizing soft tissue infections. Postgrad Med J (1999) 1.46
Imaging of musculoskeletal soft tissue infections. Skeletal Radiol (2009) 1.21
Necrotizing fasciitis. A serious sequela of omphalitis in the newborn. Ann Surg (1984) 0.94
Necrotizing fasciitis. Indian J Plast Surg (2013) 0.93
Necrotizing fasciitis--the hazards of delay. J R Soc Med (1995) 0.89
A cluster of cases of streptococcal necrotizing fasciitis in Gloucestershire. Epidemiol Infect (1995) 0.89
[Diagnosis and therapy of sepsis]. Clin Res Cardiol (2006) 0.87
Necrotizing soft-tissue infections of the perineum and genitalia. Etiology and early reconstruction. West J Med (1986) 0.81
Predictors of Monomicrobial Necrotizing Soft Tissue Infections. Surg Infect (Larchmt) (2015) 0.78
Necrotizing Fasciitis: A Study of 48 Cases. Indian J Surg (2013) 0.75
Clinico-Microbiological Aspects of Necrotising Fasciitis in Type II Diabetes Mellitus. Indian J Surg (2011) 0.75
Severe monobacterial necrotizing soft tissue infection by group A Streptococcus: A surgical emergency. Asian Pac J Trop Biomed (2012) 0.75
Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA (1994) 2.71
Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet (1979) 2.71
Early enteral administration of a formula (Impact) supplemented with arginine, nucleotides, and fish oil in intensive care unit patients: results of a multicenter, prospective, randomized, clinical trial. Crit Care Med (1995) 2.63
Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg (1991) 2.24
Preoperative optimization of cardiovascular hemodynamics improves outcome in peripheral vascular surgery. A prospective, randomized clinical trial. Ann Surg (1991) 2.21
Physiological and metabolic correlations in human sepsis. Invited commentary. Surgery (1979) 1.58
Pulmonary artery catheterization. Can there be an integrated strategy for guideline development and research promotion? JAMA (1993) 1.51
Primary hepatocytes outperform Hep G2 cells as the source of biotransformation functions in a bioartificial liver. Ann Surg (1994) 1.46
Urinary urea nitrogen: too insensitive for calculating nitrogen balance studies in surgical clinical nutrition. JPEN J Parenter Enteral Nutr (1991) 1.42
The hepatic failure of sepsis: cellular versus substrate. Surgery (1979) 1.32
Applied nutrition in ICU patients. A consensus statement of the American College of Chest Physicians. Chest (1997) 1.29
Comparative nephrotoxicity of gentamicin and tobramycin: pharmacokinetic and clinical studies in 201 patients. Antimicrob Agents Chemother (1981) 1.27
Hypermetabolism, organ failure, and metabolic support. Surgery (1987) 1.26
Late development of hydrothorax and hydromediastinum in patients with central venous catheters. Crit Care Med (1982) 1.23
Branched chains support postoperative protein synthesis. Surgery (1982) 1.18
Killed Escherichia coli stimulates macrophage-mediated alterations in hepatocellular function during in vitro coculture: a mechanism of altered liver function in sepsis. Infect Immun (1985) 1.16
Septic autocannibalism. A failure of exogenous nutritional support. Ann Surg (1980) 1.13
Evolution of the bioartificial liver: the need for randomized clinical trials. Am J Surg (1993) 1.11
Mechanistics of formation and ultrastructural evaluation of hepatocyte spheroids. In Vitro Cell Dev Biol Anim (1996) 1.11
Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress. Ann Surg (1984) 1.07
The systemic septic response: does the organism matter? Crit Care Med (1980) 1.07
Distinct patterns of cyclin D1 regulation in models of liver regeneration and human liver. Biochem Biophys Res Commun (1995) 1.04
Hemodynamic, respiratory, and metabolic effects of laparoscopic cholecystectomy. Am J Surg (1993) 1.03
Metabolism during hepatic transplantation: indicators of allograft function. Surgery (1984) 1.02
A model for reimplantation and transplantation of a complex organ: the rat hind limb. J Surg Res (1978) 1.01
Paranasal sinusitis: a common complication of nasotracheal intubation in neurosurgical patients. Neurosurgery (1985) 1.00
Regulation of murine splenocyte responses by heparan sulfate. J Immunol (1991) 0.99
Multiple systems organ failure: I. The basal state. J Trauma (1981) 0.99
Fatty acid intake and Kupffer cell function: fish oil alters eicosanoid and monokine production to endotoxin stimulation. Surgery (1988) 0.99
Efficient assembly of rat hepatocyte spheroids for tissue engineering applications. Biotechnol Bioeng (1996) 0.99
Gel-entrapment bioartificial liver therapy in galactosamine hepatitis. J Surg Res (1995) 0.98
Hepatocyte function in a hollow fiber bioreactor: a potential bioartificial liver. J Surg Res (1992) 0.97
Conformer selection of protein ions by ion mobility in a triple quadrupole mass spectrometer. J Am Soc Mass Spectrom (1994) 0.97
Correlations between metabolic and cardiopulmonary measurements in patients after trauma, general surgery, and sepsis. J Trauma (1979) 0.97
Endotoxin modulation of hepatocyte secretory and cellular protein synthesis is mediated by Kupffer cells. Arch Surg (1988) 0.96
Clinical and pharmacokinetic characteristics of aminoglycoside nephrotoxicity in 201 critically ill patients. Antimicrob Agents Chemother (1982) 0.95
Formation of porcine hepatocyte spheroids for use in a bioartificial liver. Cell Transplant (1995) 0.95
Modulation of macrophage and B cell function by glycosaminoglycans. J Leukoc Biol (1999) 0.94
Evaluation of a hepatocyte-entrapment hollow fiber bioreactor: a potential bioartificial liver. Biotechnol Bioeng (1993) 0.94
Nitrogen retention in critically ill patients is proportional to the branched chain amino acid load. Crit Care Med (1983) 0.93
Evidence based critical care medicine; what is it and what can it do for us? Evidence Based Medicine in Critical Care Group. Crit Care Med (1996) 0.92
Enhanced survival during murine gram-negative bacterial sepsis by use of a murine monoclonal antibody. Arch Surg (1985) 0.92
Characterization of the three-compartment gel-entrapment porcine hepatocyte bioartificial liver. Cell Biol Toxicol (1997) 0.92
Multiple systems organ failure. Modulation of hepatocyte protein synthesis by endotoxin activated Kupffer cells. Ann Surg (1985) 0.91
The effect of dietary glutamine and dietary RNA on ileal flora, ileal histology, and bacterial translocation in mice. Nutrition (1992) 0.91
Altered aminoglycoside pharmacokinetics in critically ill patients with sepsis. Clin Pharm (1987) 0.90
The effect on survival of critically ill and injured patients of an ICU teaching service organized about a computer-based physiologic CARE system. J Trauma (1980) 0.90
Efficacy of type-specific and cross-reactive murine monoclonal antibodies directed against endotoxin during experimental sepsis. Surgery (1985) 0.90
Dietary omega-3 fatty acids decrease mortality and Kupffer cell prostaglandin E2 production in a rat model of chronic sepsis. J Trauma (1991) 0.90
Intestinal bacterial flora, intestinal pathology, and lipopolysaccharide-induced translocation of intestinal bacteria. Circ Shock (1992) 0.89
Secondary organ dysfunction. From clinical perspectives to molecular mediators. Crit Care Clin (1993) 0.89
An anesthetized model of lethal canine galactosamine fulminant hepatic failure. Hepatology (1995) 0.89
Pancreatic function after normothermic ischemia. II. Cadaveric transplantation. Am J Surg (1970) 0.89
Disease-specific amino acid infusion (F080) in hepatic encephalopathy: a prospective, randomized, double-blind, controlled trial. JPEN J Parenter Enteral Nutr (1985) 0.88
Hepatocyte function in sepsis: Kupffer cells mediate a biphasic protein synthesis response in hepatocytes after exposure to endotoxin or killed Escherichia coli. Surgery (1985) 0.88
Extended liver-specific functions of porcine hepatocyte spheroids entrapped in collagen gel. In Vitro Cell Dev Biol Anim (1995) 0.88
Enhanced cytochrome P450 IA1 activity of self-assembled rat hepatocyte spheroids. Cell Transplant (1999) 0.88
Amino acid alterations and encephalopathy in the sepsis syndrome. Crit Care Med (1991) 0.88
Pathologic synergy in cardiovascular and respiratory compensation with cirrhosis and sepsis. A manifestation of a common metabolic defect? Arch Surg (1982) 0.88
Heparan sulfate initiates signals in murine macrophages leading to divergent biologic outcomes. J Immunol (1995) 0.87
Selective intra-arterial vasopressin: clinical efficacy and complications. Ann Surg (1979) 0.87
Paranasal sinusitis associated with nasotracheal intubation: a frequently unrecognized and treatable source of sepsis. Crit Care Med (1986) 0.87
Hemorrhagic infarction: A reperfusion injury following prolonged myocardial ischemic anoxia. Surgery (1975) 0.87
Enteral feeding in sepsis: a prospective, randomized, double-blind trial. Surgery (1985) 0.86
Dose and serum concentration relationships in cimetidine-associated mental confusion. Gastroenterology (1980) 0.86
Modulation of hepatocyte protein synthesis by endotoxin-activated Kupffer cells. II. Mediation by soluble transferrable factors. Ann Surg (1985) 0.86
Direct effects of endotoxin on hepatocytes. Synthesis of a specific secretory protein. Arch Surg (1988) 0.85
The endothelial damage of pulsatile renal preservation and its relationship to perfusion pressure and colloid osmotic pressure. Surgery (1977) 0.85
Decreased hepatic clearance of clindamycin in critically ill patients with sepsis. Clin Pharm (1987) 0.85
Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience? Gynecol Oncol (1993) 0.85
Specific interaction between beta-lactams and soluble penicillin-binding protein 2a from methicillin-resistant Staphylococcus aureus: development of a chromogenic assay. Antimicrob Agents Chemother (1996) 0.85
Sengstaken-Blakemore tube placement. Use of balloon tamponade to control bleeding varices. Crit Care Clin (1992) 0.85
Proline metabolism in sepsis, cirrhosis and general surgery. The peripheral energy deficit. Ann Surg (1979) 0.84
Immunoprotection of xenocytes in a hollow fiber bioartificial liver. ASAIO J (1993) 0.84
Pancreatic function after normothermic ischemia. I. In vivo ischemia. Am J Surg (1970) 0.84
Primary culture of rat hepatocytes entrapped in cylindrical collagen gels: an in vitro system with application to the bioartificial liver. Rat hepatocytes cultured in cylindrical collagen gels. Cytotechnology (1992) 0.84
The role of heparin in guinea pig gram negative bacterial sepsis. J Surg Res (1983) 0.83
Extracorporeal application of a gel-entrapment, bioartificial liver: demonstration of drug metabolism and other biochemical functions. Cell Transplant (1994) 0.83
Effects of hepatocyte growth factor on viability and biotransformation functions of hepatocytes in gel entrapped and monolayer culture. Crit Care Med (1995) 0.83
Modulation of hepatocyte protein synthesis during co-cultivation with macrophage-rich peritoneal cells in vitro. Arch Surg (1985) 0.83
Cutaneous malignant lymphoma: skin ulcer of lower leg. N Y State J Med (1979) 0.83
Left ventricular function in malnutrition. Am J Physiol (1987) 0.82
Intrapatient variation of aminoglycoside pharmacokinetics in critically ill surgery patients. Clin Pharm (1988) 0.82
Macrophage-mediated modulation of hepatic function in multiple-system failure. J Surg Res (1985) 0.82
Hollow fiber bioartificial liver utilizing collagen-entrapped porcine hepatocyte spheroids. Biotechnol Bioeng (1996) 0.82
Immunotherapy of gram-negative bacterial sepsis. A single murine monoclonal antibody provides cross-genera protection. Arch Surg (1986) 0.82
Modulation of hepatocyte protein synthesis by endotoxin-activated Kupffer cells. III. Evidence for the role of a monokine similar to but not identical with interleukin-1. Ann Surg (1985) 0.81
Initial management of trauma. The next 60 minutes. Postgrad Med (1990) 0.81
Amikacin and gentamicin accumulation pharmacokinetics and nephrotoxicity in critically ill patients. Antimicrob Agents Chemother (1981) 0.81
Characterization of an echinocandin B-producing strain blocked for sterigmatocystin biosynthesis reveals a translocation in the stcW gene of the aflatoxin biosynthetic pathway. J Ind Microbiol Biotechnol (2000) 0.81
Amino acid abnormalities in infants with extrahepatic biliary atresia and cirrhosis. J Pediatr Gastroenterol Nutr (1988) 0.81
Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support). Crit Care Med (1992) 0.81
Physiological and metabolic response to isolated closed-head injury. Part 2: Effects of steroids on metabolism. Potentiation of protein wasting and abnormalities of substrate utilization. J Neurosurg (1987) 0.81
Modulation of Kupffer cell membrane phospholipid function by n-3 polyunsaturated fatty acids. J Surg Res (1989) 0.81
Structural-functional correlates of reversible myocardial anoxia. J Surg Res (1974) 0.81
Thrombolytic therapy for postoperative pulmonary embolism. Am J Surg (1992) 0.81
Modulation of cytolytic T cell responses by heparan sulfate. Transplantation (1994) 0.80
Effect of a diet deficient in essential fatty acids on the translocation of intestinal bacteria. JPEN J Parenter Enteral Nutr (1992) 0.80